|
"perng rp"的相關文件
顯示項目 51-58 / 58 (共3頁)
<< < 1 2 3
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2000 |
Phase II study of docetaxel plus gemcitabine in patients with non-small cell lung cancer (NSCLC) that failed previous chemotherapy (CT)
|
Chen, YM;Perng, RP;Whang-Peng, J;Lin, WC;Wu, HW;Tsai, CM |
| 國家衛生研究院 |
1999-09 |
A multi-centre phase II trial of gemcitabine (GEM) and vinorelbine (VRL) in patients (PTS) with stage III-IV non small cell lung cancer (NSCLC)
|
Chen, YM;Perng, RP;Peng, JW;Liu, TW;Yang, KY;Lin, WC;Wu, HW;Shih, JF;Liu, JM;Chen, LT;Tsai, CM |
| 國家衛生研究院 |
1998-03 |
Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions
|
Perng, RP; Chen, YM; Wu, MF; Chou, KC; Lin, WC; Liu, JM; Whang-Peng, J |
| 國家衛生研究院 |
1997-10 |
Cross regulation by IL-10 and 1L-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients
|
Chen, YM; Yang, WK; Ting, CC; Tsai, WY; Yang, DM; WhangPeng, J; Perng, RP |
| 國家衛生研究院 |
1997-09 |
Restoration of the immunocompetence by IL-2 activation and TCR-CD3 engagement of the in vivo anergized tumor-specific CTL from lung cancer patients
|
Chen, YM; Yang, WK; WhangPeng, J; Tsai, WY; Hung, YM; Yang, DM; Lin, WC; Perng, RP; Ting, CC |
| 國家衛生研究院 |
1997-07 |
A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions
|
Perng, RP;Wu, MF;Lin, SY;Chen, YM;Lin, JY;WhangPeng, J |
| 國家衛生研究院 |
1997-05 |
Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study
|
Perng, RP; Chen, YM; MingLiu, J; Tsai, CM; Lin, WC; Yang, KY; WhangPeng, J |
| 國家衛生研究院 |
1997-04 |
Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer
|
Chen, YM;Wu, MF;Perng, RP;Chou, CM;Yang, KY;Lin, WC;Tsai, CM;Liu, JM;WhangPeng, J |
顯示項目 51-58 / 58 (共3頁)
<< < 1 2 3
每頁顯示[10|25|50]項目
|
